Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

BeiGene patents new PROTACs for cancer

April 20, 2021

Genentech's GNE-7883 inhibits YAP/TAZ-TEAD interaction

April 20, 2021

Zenshine PI3Kgamma inhibitor ZX-4081 functions by reprogramming the tumor microenvironment

April 20, 2021

Loxo Oncology presents next-generation RET inhibitor candidates

April 19, 2021

Shenzhen Targetrx Biotechnology synthesizes Ret inhibitors

April 19, 2021

Medshine Discovery presents new BTK inhibitors

April 19, 2021

Beijing Jacobio Pharmaceuticals divulges new KRAS inhibitors

April 19, 2021

Phase I study of eryaspase in first-line pancreatic cancer escalates to next cohort

April 19, 2021

Phase III study of chiauranib in SCLC begins

April 19, 2021

Ideaya reports preliminary phase I/II data on darovasertib in metastatic uveal melanoma

April 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026